First (1), the primitive cells from the Lin-CD34+CD38-/low fraction of all CML patients were merged and classified by BCR::ABL1 status using publicly available BCR::ABL1+ gene signatures. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.